ABOUT
Aims and Scope
About the KJM
General Information
Editorial Board
Best Pracitce
Open Access
BROWSE ARTICLES
All issues
Accepted Articles
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
EDITORIAL POLICY
Research and Publication Ethics
Peer Review Policy
Preprints Policy
Advertising Policy
Data archiving Policy
Data sharing Policy
FOR CONTRIBUTORS
Instructions for Authors
Copyright Transfer Agreements
Article-processing Charge
E-Submission
Search
Close
PDF
Share
Facebook
Twitter
Google
LinkedIn
Metrics
Review
Korean J Med.
2008;75(1):372-372.
HBeAg 양성 만성 B형간염환자의 라미부딘치료 예후인자로서 24주 HBV-DNA의 감소폭 (초)
황승재, 설혜령, 정선주, 정승문, 최종학, 이현웅, 김형준
,
,
,
,
,
,
